Wei‐Tien Tai

2.2k total citations
37 papers, 1.8k citations indexed

About

Wei‐Tien Tai is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Wei‐Tien Tai has authored 37 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 22 papers in Oncology and 14 papers in Pathology and Forensic Medicine. Recurrent topics in Wei‐Tien Tai's work include Protein Tyrosine Phosphatases (17 papers), Cytokine Signaling Pathways and Interactions (17 papers) and Cancer Mechanisms and Therapy (13 papers). Wei‐Tien Tai is often cited by papers focused on Protein Tyrosine Phosphatases (17 papers), Cytokine Signaling Pathways and Interactions (17 papers) and Cancer Mechanisms and Therapy (13 papers). Wei‐Tien Tai collaborates with scholars based in Taiwan, United States and South Korea. Wei‐Tien Tai's co-authors include Kuen‐Feng Chen, Chung-Wai Shiau, Pei‐Jer Chen, Ann‐Lii Cheng, Chun‐Yu Liu, Jui-Wen Huang, Hsiang–Po Huang, Hui‐Ling Chen, Wen-Chi Feng and Pei‐Yi Chu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Hepatology.

In The Last Decade

Wei‐Tien Tai

37 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei‐Tien Tai Taiwan 25 1.1k 642 409 405 344 37 1.8k
Sachiko Ogasawara Japan 22 740 0.6× 519 0.8× 173 0.4× 433 1.1× 406 1.2× 78 1.6k
Ming‐Hai Wang United States 32 1.3k 1.1× 808 1.3× 245 0.6× 880 2.2× 265 0.8× 66 2.5k
Bazarragchaa Damdinsuren Japan 28 858 0.8× 802 1.2× 280 0.7× 563 1.4× 485 1.4× 42 2.3k
Agrin Moeini Spain 16 648 0.6× 587 0.9× 213 0.5× 373 0.9× 497 1.4× 22 1.7k
Roberta Pang Hong Kong 29 1.6k 1.4× 1.1k 1.7× 383 0.9× 815 2.0× 987 2.9× 53 3.0k
Annalisa Petrelli Italy 19 1.4k 1.2× 490 0.8× 132 0.3× 312 0.8× 470 1.4× 26 2.1k
Miriam Farina Italy 10 837 0.7× 332 0.5× 203 0.5× 241 0.6× 393 1.1× 20 1.5k
Guo‐Ming Shi China 20 1.0k 0.9× 691 1.1× 206 0.5× 213 0.5× 622 1.8× 38 2.1k
Sandrine Boyault France 14 1.0k 0.9× 351 0.5× 238 0.6× 503 1.2× 503 1.5× 20 1.7k
Mina Maftouh Iran 26 1.2k 1.1× 648 1.0× 204 0.5× 104 0.3× 752 2.2× 39 1.9k

Countries citing papers authored by Wei‐Tien Tai

Since Specialization
Citations

This map shows the geographic impact of Wei‐Tien Tai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Tien Tai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Tien Tai more than expected).

Fields of papers citing papers by Wei‐Tien Tai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei‐Tien Tai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Tien Tai. The network helps show where Wei‐Tien Tai may publish in the future.

Co-authorship network of co-authors of Wei‐Tien Tai

This figure shows the co-authorship network connecting the top 25 collaborators of Wei‐Tien Tai. A scholar is included among the top collaborators of Wei‐Tien Tai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei‐Tien Tai. Wei‐Tien Tai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Su, Tung‐Hung, Chung-Wai Shiau, Wei‐Tien Tai, et al.. (2017). Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis. Scientific Reports. 7(1). 1728–1728. 16 indexed citations
2.
Tai, Wei‐Tien, Yao‐Li Chen, Pei‐Yi Chu, et al.. (2016). Protein tyrosine phosphatase 1B dephosphorylates PITX1 and regulates p120RasGAP in hepatocellular carcinoma. Hepatology. 63(5). 1528–1543. 36 indexed citations
3.
Su, Jung-Chen, Szu‐Hsien Wu, Wei‐Tien Tai, et al.. (2016). Disrupting VEGF-A paracrine and autocrine loops by targeting SHP-1 suppresses triple negative breast cancer metastasis. Scientific Reports. 6(1). 28888–28888. 50 indexed citations
4.
Tai, Wei‐Tien, et al.. (2015). A combination of sorafenib and SC-43 is a synergistic SHP-1 agonist duo to advance hepatocellular carcinoma therapy. Cancer Letters. 371(2). 205–213. 28 indexed citations
5.
Teng, Hao‐Wei, Chung-Wai Shiau, Wei‐Tien Tai, et al.. (2015). Pharmacological Targeting SHP-1-STAT3 Signaling Is a Promising Therapeutic Approach for the Treatment of Colorectal Cancer. Neoplasia. 17(9). 687–696. 29 indexed citations
6.
Tseng, Ping‐Hui, Szu‐Hsien Wu, Wei‐Tien Tai, et al.. (2014). SC-2001 Overcomes STAT3-mediated Sorafenib Resistance through RFX-1/SHP-1 Activation in Hepatocellular Carcinoma. Neoplasia. 16(7). 595–605. 43 indexed citations
7.
Liu, Chun‐Yu, Ling‐Ming Tseng, Pei‐Yi Chu, et al.. (2014). Obatoclax analog SC-2001 inhibits STAT3 phosphorylation through enhancing SHP-1 expression and induces apoptosis in human breast cancer cells. Breast Cancer Research and Treatment. 146(1). 71–84. 12 indexed citations
8.
Wang, Cheng‐Yi, Ting-Ting Chao, Wei‐Tien Tai, et al.. (2014). Signal Transducer and Activator of Transcription 3 as Molecular Therapy for Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology. 9(4). 488–496. 9 indexed citations
9.
10.
Tai, Wei‐Tien, Chung-Wai Shiau, Yao-Li Chen, et al.. (2013). SC-60, a Dimer-Based Sorafenib Derivative, Shows a Better Anti–Hepatocellular Carcinoma Effect than Sorafenib in a Preclinical Hepatocellular Carcinoma Model. Molecular Cancer Therapeutics. 13(1). 27–36. 7 indexed citations
11.
Tai, Wei‐Tien, Chung-Wai Shiau, Pei‐Jer Chen, et al.. (2013). Discovery of novel src homology region 2 domain-containing phosphatase 1 agonists from sorafenib for the treatment of hepatocellular carcinoma. Hepatology. 59(1). 190–201. 66 indexed citations
12.
Lin, Chen‐Si, et al.. (2013). Nilotinib Induces Autophagy in Hepatocellular Carcinoma through AMPK Activation. Journal of Biological Chemistry. 288(25). 18249–18259. 80 indexed citations
13.
Chen, Kuen‐Feng, Hui‐Ling Chen, Chun‐Yu Liu, et al.. (2012). Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3. Biochemical Pharmacology. 83(6). 769–777. 41 indexed citations
14.
Chen, Kuen‐Feng, Jung-Chen Su, Chun‐Yu Liu, et al.. (2012). A novel obatoclax derivative, SC-2001, induces apoptosis in hepatocellular carcinoma cells through SHP-1-dependent STAT3 inactivation. Cancer Letters. 321(1). 27–35. 44 indexed citations
15.
Chen, Kuen‐Feng, Weilin Chen, Chun‐Yu Liu, et al.. (2012). Synthesis and biological activity of obatoclax derivatives as novel and potent SHP-1 agonists. European Journal of Medicinal Chemistry. 56. 127–133. 21 indexed citations
16.
Chen, Kuen‐Feng, Jing‐Ping Lin, Chung-Wai Shiau, et al.. (2012). Inhibition of Bcl-2 improves effect of LCL161, a SMAC mimetic, in hepatocellular carcinoma cells. Biochemical Pharmacology. 84(3). 268–277. 51 indexed citations
17.
Wang, Chen‐Ti, Chen‐Si Lin, Chung‐Wai Shiau, et al.. (2012). SC‐1, a sorafenib derivative, shows anti‐tumor effects in osteogenic sarcoma cells. Journal of Orthopaedic Research®. 31(2). 335–342. 7 indexed citations
18.
Chen, Kuen‐Feng, Wei‐Tien Tai, Jui-Wen Huang, et al.. (2012). Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity. European Journal of Medicinal Chemistry. 55. 220–227. 73 indexed citations
19.
Tai, Wei‐Tien, Ann‐Lii Cheng, Chung-Wai Shiau, et al.. (2011). Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma. Journal of Hepatology. 55(5). 1041–1048. 141 indexed citations
20.
Chen, Kuen‐Feng, Hui‐Ling Chen, Wei‐Tien Tai, et al.. (2011). Activation of Phosphatidylinositol 3-Kinase/Akt Signaling Pathway Mediates Acquired Resistance to Sorafenib in Hepatocellular Carcinoma Cells. Journal of Pharmacology and Experimental Therapeutics. 337(1). 155–161. 265 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sachiko Ogasawara Breakdown of academic impact, for papers by Ming‐Hai Wang Breakdown of academic impact, for papers by Bazarragchaa Damdinsuren Breakdown of academic impact, for papers by Agrin Moeini Breakdown of academic impact, for papers by Roberta Pang Breakdown of academic impact, for papers by Annalisa Petrelli Breakdown of academic impact, for papers by Miriam Farina Breakdown of academic impact, for papers by Guo‐Ming Shi Breakdown of academic impact, for papers by Sandrine Boyault Breakdown of academic impact, for papers by Mina Maftouh
Rankless by CCL
2026